McKesson (NYSE:MCK) Trading 0.3% Higher

McKesson Co. (NYSE:MCK - Get Free Report) traded up 0.3% during trading on Wednesday . The company traded as high as $557.95 and last traded at $553.83. 145,637 shares were traded during trading, a decline of 79% from the average session volume of 705,362 shares. The stock had previously closed at $552.39.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Robert W. Baird upped their price objective on shares of McKesson from $603.00 to $671.00 and gave the company an "outperform" rating in a research note on Wednesday, May 8th. Evercore ISI upped their price target on McKesson from $590.00 to $600.00 and gave the stock an "outperform" rating in a report on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft reduced their target price on McKesson from $547.00 to $545.00 and set a "buy" rating for the company in a research note on Thursday, May 9th. Barclays increased their target price on McKesson from $571.00 to $596.00 and gave the company an "overweight" rating in a research note on Wednesday, May 8th. Finally, Wells Fargo & Company upped their price target on McKesson from $502.00 to $551.00 and gave the company an "equal weight" rating in a research report on Thursday, May 9th. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, McKesson presently has an average rating of "Moderate Buy" and an average target price of $571.47.

McKesson Trading Up 0.9 %

The company has a 50 day moving average of $536.78 and a 200 day moving average of $501.09. The firm has a market cap of $72.45 billion, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 1.33 and a beta of 0.45.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.34 by ($0.16). McKesson had a net margin of 0.97% and a negative return on equity of 245.88%. The business had revenue of $76.36 billion during the quarter, compared to the consensus estimate of $79.32 billion. During the same quarter in the previous year, the firm posted $7.19 EPS. The company's revenue for the quarter was up 10.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that McKesson Co. will post 31.55 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a $0.62 dividend. The ex-dividend date is Monday, June 3rd. This represents a $2.48 annualized dividend and a yield of 0.44%. McKesson's payout ratio is 11.08%.

Insider Transactions at McKesson

In other news, Director Susan R. Salka sold 606 shares of the business's stock in a transaction on Friday, May 10th. The stock was sold at an average price of $558.04, for a total transaction of $338,172.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Susan R. Salka sold 606 shares of the company's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $558.04, for a total value of $338,172.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Brian S. Tyler sold 3,473 shares of the company's stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company's stock, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. Insiders sold a total of 4,080 shares of company stock worth $2,160,489 over the last 90 days. 0.21% of the stock is owned by insiders.

Institutional Investors Weigh In On McKesson

Several large investors have recently modified their holdings of the business. Sachetta LLC acquired a new stake in McKesson in the 4th quarter valued at approximately $27,000. LRI Investments LLC acquired a new stake in McKesson in the 1st quarter valued at approximately $28,000. Register Financial Advisors LLC acquired a new stake in McKesson in the 1st quarter valued at approximately $29,000. BKM Wealth Management LLC acquired a new stake in McKesson in the 4th quarter valued at approximately $31,000. Finally, Richardson Financial Services Inc. acquired a new position in shares of McKesson during the 4th quarter worth approximately $31,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.